<!DOCTYPE html>
<html lang="en">
<head>
<title>Malaria</title>
<meta http-equiv="Content-Type" content="text/html;charset=utf-8">
<link rel="stylesheet" type="text/css" href="../../../public/css/offline.css" />
<script src="../../../public/javascripts/jquery-1.10.2.min.js"></script>
</head>
<body class="dsg-wb">

<table width="80%" class="offline">
<tr>
  <td colspan="3" class="header"><h1><a href="/">JPAC</a> <span>Joint United Kingdom (UK) Blood Transfusion and Tissue Transplantation Services Professional Advisory Committee</span></h1></td>
</tr>
<tr class="tabs">
  <td colspan="3">
              <ul>
                  <li id="64df60ce-a8e2-4c07-8729-68f41eb42fc3" class="whole-blood-and-components"><a href="../../../dsg/wb/guidelines.html"  class="active">Whole Blood and Components</a></li>
                  <li id="ddb09bf2-3dc0-4eb2-ba57-a5db69331dd1" class="geographical-disease-risk-index"><a href="../../../dsg/gdri/guidelines.html" >Geographical Disease Risk Index</a></li>
                </ul>
        </td>
</tr>
<tr>
  <td class="spacerow" colspan="3"></td>
</tr>
<tr>
  <td class="sidebar" width="25%">
    <div class="well">
          <ul class="openContentSectionWithSubs sidebarTopHeader"><li id="64df60ce-a8e2-4c07-8729-68f41eb42fc3" class="whole-blood-and-components sectionHead first last"><a href="../../../dsg/wb.html">Whole Blood and Components</a>
<ul class="">
<li id="42be2de8-89aa-4908-8bc8-702f9e636a81" class="a-z-search active first"><a href="../../../dsg/wb/guidelines.html">A-Z Search</a>
</li><li id="1f7e1f13-8b29-4772-ae9d-2b5cc3d59491" class="updates"><a href="../../../dsg/wb/latest-updates.html">Updates</a>
</li><li id="f83d68fb-19de-4588-9a36-a8bba0aa6494" class="drug-index"><a href="../../../dsg/wb/drug-index.html">Drug Index</a>

</li><li id="769da873-1c35-4600-8be8-d2df902570a0" class="preliminaries"><a href="../../../dsg/wb/preliminaries.html">Preliminaries</a>
<ul class="">
<li id="258895c3-f3dd-45c6-932c-3fe4795870c2" class="introduction first"><a href="../../../dsg/wb/preliminaries/introduction.html">Introduction</a>
</li><li id="ef298454-8327-4f6c-9f4a-835e437df103" class="document-and-change-control"><a href="../../../dsg/wb/preliminaries/document-and-change-control.html">Document and Change Control</a>
</li><li id="093e6463-a089-49dd-9199-c8f92559f486" class="general-principles"><a href="../../../dsg/wb/preliminaries/general-principles.html">General Principles</a>
</li><li id="96f75c3a-2c62-445b-847c-353098eaec1e" class="medication"><a href="../../../dsg/wb/preliminaries/medication.html">Medication</a>
</li><li id="ed51942d-a7fd-42f7-8269-d23b879f99ca" class="inspection-of-the-donor"><a href="../../../dsg/wb/preliminaries/inspection-of-the-donor.html">Inspection of the Donor</a>
</li><li id="99af8b5e-491b-4d67-b69a-812d81af4d7d" class="use-of-alphabetical-listing last"><a href="../../../dsg/wb/preliminaries/use-of-alphabetical-listing.html">Use of Alphabetical Listing</a>
</li></ul>
</li><li id="753eb36f-2636-414c-84ee-1004e197502d" class="appendices"><a href="../../../dsg/wb/appendicies.html">Appendices</a>
<ul class="">
<li id="e147bd96-a025-4ffa-b530-b9abefc27043" class="appendix-1---estimated-blood-volume-for-female-donors-after-nadler--by-height-and-weight first"><a href="../../../dsg/wb/appendicies/appendix-1.html">Appendix 1 - Estimated Blood Volume for Female donors (after Nadler)  by height and weight</a>
</li><li id="2f1eca54-e34f-4ece-90a4-7dfe0f210c8d" class="appendix-2---table-of-immunisations-"><a href="../../../dsg/wb/appendicies/appendix-2-table-of-immunizations.html">Appendix 2 - Table of Immunisations </a>
</li><li id="a27f8ce9-b4f6-4a9b-baf0-6f655955a9aa" class="appendix-3---maximum-permitted-ecv-for-component-donors"><a href="../../../dsg/wb/appendicies/appendix-3-maximum-permitted-extra-corporeal-volume-for-component-donors.html">Appendix 3 - Maximum permitted ECV for component donors</a>
</li><li id="90c869cb-7256-4604-8699-d8a86f78aa26" class="appendix-4---management-of-post-donation-illness last"><a href="../../../dsg/wb/appendicies/appendix-4-management-of-post-donation-illness.html">Appendix 4 - Management of post donation illness</a>
</li></ul>
</li><li id="b62a2d12-6d94-4106-92a8-1de426a4b863" class="source-files last"><a href="../../../dsg/wb/source-files.html">Source Files</a>
</li></ul>
</li></ul>
    </div>
  </td>
  <td width="5%"></td>
  <td width="70%" class="content">
    <h2>Malaria</h2>    

<table class="data-table"><tbody><tr class="data-row"><td class="data-label">Excludes</td><td class="data-value"><p>Donors who will only donate plasma for fractionation. See <a href="../../../dsg/wb/guidelines/malaria-plasmapheresis-donors.html">Malaria&nbsp;- plasmapheresis donors</a></p></td></tr><tr class="data-row"><td class="data-label">Obligatory</td><td class="data-value"><p><strong>Must not donate if:</strong></p>


<p>a) The donor has ever had malaria.</p>


<p><br />
b) The donor has had an undiagnosed fever (which could have been malaria) while abroad or within four months of leaving a malaria endemic area.</p>


<p><br />
c) The donor has lived in any malarial endemic area for a continuous period of six months or more at any time of life.</p>


<p><br />
d) Less than 12 months after last leaving a malaria endemic area.</p></td></tr><tr class="data-row"><td class="data-label">Discretionary</td><td class="data-value"><p><strong>a) Donors who have had malaria diagnosed in the past:</strong><br />
If more than three years have passed since anti-malarial therapy has been completed and symptoms caused by malaria have resolved and a validated test for malarial antibody is to be performed, accept.</p>


<p><br />
If the donor (with a history of malaria) has revisited a malaria endemic area and at least four months have passed since return and a validated test for malarial antibody is to be performed, accept.</p>


<p><br />
<strong>b) Donors who have EVER had an undiagnosed fever that could have been malaria while in a malarial area or within four months of leaving a malaria endemic area:</strong><br />
If at least four months have passed since the donor returned from the malarial endemic area, or from the date of recovery from symptoms (undiagnosed fever) that may have been caused by malaria, whichever is later, and a validated test for malarial antibody is to be performed, accept.<br />
<br />
NB. this may have to be increased to six months if the area is also identified as a risk area for T.cruzi or a tropical virus; the longest stipulated deferral period must be applied</p>


<p><br />
<strong>c) Donors who have EVER been resident in a malarial endemic area for 6 months or more:</strong><br />
If at least four months has passed since the date of the last potential exposure to malaria, and a validated test for malaria antibody is to be performed, accept.</p>


<p><br />
<strong>d) For all other donors:</strong><br />
If at least four months and less than 12 months have passed since return from a malaria endemic area, and a validated test for malarial antibody is to be performed, accept.</p></td></tr><tr class="data-row"><td class="data-label">See if Relevant</td><td class="data-value"><p><a href="../../../dsg/gdri.html">The 'Geographical Disease Risk Index'</a> for countries with a current endemic malaria risk.</p></td></tr><tr class="data-row"><td class="data-label">Additional Information</td><td class="data-value"><p>Cases of transfusion transmitted malaria have occurred many years after the donor was last at risk of becoming infected with malaria. This is mainly a problem in people who have had repeated episodes of infection with malaria. Although this is uncommon, before allowing someone who has had, or may have had, malaria to donate, it is safer to test for malaria antibodies rather than to wait a specific length of time. Transfusion transmitted malaria is often fatal.</p></td></tr><tr class="data-row"><td class="data-label">Information</td><td class="data-value"><p>This is a requirement of the Blood Safety and Quality Regulations 2005.</p></td></tr><tr class="data-row"><td class="data-label">Reason for change</td><td class="data-value"><p>Entry updated to exclude donors who will only donate plasma for fractionation.</p></td></tr><tr class="data-row"><td class="data-label">Donor Information</td><td class="data-value"><p>If you wish to obtain more information regarding a personal medical issue please contact your <a href="../../../dsg/wb/guidelines/nn099-national-help-lines.html">National Help Line</a>.<br />
<br />
Please do not contact this web site for personal medical queries, as we are not in a position to provide individual answers.</p></td></tr></tbody></table>
<div class="pull-right attachments"><div class="cms images">
  
</div></div>

  
<dl class="update-information"><dt class="data-label"><h4>Update Information</h4></dt><dd class="data-value"><p>This entry was last updated in:<br />
WB-DSG&nbsp;Edition 203&nbsp;Release 71</p></dd></dl>  </td>
</tr>
</table>
</body>
</html>